Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab

British Journal of Ophthalmology

Volumn 93, Issue 5, 2009, Pages 610-613

  Lee, A Y ^a   Raya, A K ^a   Kymes, S M ^a   Shiels, A ^a   Brantley Jr , M A ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES RETINA INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; RANIBIZUMAB; ANGIOGENESIS INHIBITOR; COMPLEMENT FACTOR H, HUMAN; MONOCLONAL ANTIBODY;

AGED; ALLELE; ARTICLE; CIGARETTE SMOKING; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; VISUAL ACUITY; DRUG EFFECT; GENETICS; PATHOPHYSIOLOGY; RETINA MACULA DEGENERATION; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMPLEMENT FACTOR H; FEMALE; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 66149089631     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.150995     Document Type: Article

References (15)

1. Friedman DS, O'Colmain BJ, Mufioz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-72.
2. Klein R, Klein BE, Linton KL, et el. The Beaver Dam Eye Study: the relation of age- related maculopathy to smoking. Am J Epidemiol 1993;137:190-200.
3. Scholl HP, Fleckenstein M, Charbel Issa P, et al. An update on the genetics of age- related macular degeneration. Mol Vis 2007;13:196-205.
4. Klein RJ, Zeiss C, Chew EY, etal. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-9.
5. Edwards AO, Ritter R, Abel KJ, et al. Complement factor H polymorphism and age- related macular degeneration. Science 2005;308:421-4.
6. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005;308:419-21.
7. Souied EH, Leveziel N, Richard F, et al. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis 2005;11:1135-40.
8. Seddon JM, Francis PJ, George S, et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 2007;297:1793-800.
9. Klein ML, Francis PJ, Rosner B, et al. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology 2008;115:1019-25.
10. ]10. Goverdhan SV, Hannan S, Newsom RB, et al. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment. Eye 2008;22:849-54.
11. Seitsonen SP, Jarvela IE, Meri S, et al. The effect of complement factor H Y402H polymorphism on the outcome of photodynamic therapy in age-related macular degeneration. Eur J Ophthalmol 2007;17:943-9.
12. Brantley MA Jr, Edelstein SL, King JM, et al. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy. Eye. Published Online First: 22 Feb 2008. doi:10:1038/eye.2008.28.
13. Brantley MA Jr, Fang AM, King JM, et al. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Ophthalmology 2007;114:2168-73.
14. Schmidt S, Hauser MA, Scott WK, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006;78:852-64.
15. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999;286:487-91.